Summary:
Maven Clinic closes $125 million funding round at a $1.7 billion valuation.
Founded in 2014 by Kate Ryder, Maven provides virtual care for women's reproductive health.
The company covers approximately 17 million lives through partnerships with major employers like Amazon and Microsoft.
Maven has raised over $425 million to date and aims to expand its fertility benefits and platform.
Following the Roe v. Wade ruling, Maven has seen a 67% increase in interest for pregnancy-related travel benefits.
Maven Clinic, a pioneering women's health startup, has successfully closed a $125 million funding round, achieving a remarkable $1.7 billion valuation. The announcement was made on Tuesday, marking a significant milestone for the company.
Kate Ryder, the CEO of Maven, founded the company in 2014 after witnessing friends struggle with the complexities of family planning. Today, Maven provides virtual care across various stages of the reproductive life cycle, from family planning to menopause, covering approximately 17 million lives through partnerships with health plans and employers like Amazon, Microsoft, and AT&T.
Maven's fresh capital will be invested in enhancing its fertility benefits, expanding its platform, and utilizing real-time data to deliver more proactive care. The startup has raised over $425 million to date and aims for a public offering in the future.
Ryder emphasized that digital health is just beginning, and Maven was the first U.S. startup dedicated to women's health to achieve unicorn status. The company has been recognized on the CNBC Disruptor 50 list for three consecutive years.
In the wake of the Roe v. Wade ruling, Maven has played a crucial role in helping employers navigate care gaps, witnessing a 67% increase in interest for travel benefits related to pregnancy. Ryder views the current landscape of women’s health data as critical for shaping better policies, despite the challenging circumstances following recent legal decisions.
As Maven continues to grow, it remains committed to improving access and care for women, aiming to leverage its platform for policy change in the healthcare sector.
Comments